0001209191-15-080796.txt : 20151117 0001209191-15-080796.hdr.sgml : 20151117 20151117214514 ACCESSION NUMBER: 0001209191-15-080796 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151117 FILED AS OF DATE: 20151117 DATE AS OF CHANGE: 20151117 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Revance Therapeutics, Inc. CENTRAL INDEX KEY: 0001479290 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770551645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-742-3400 MAIL ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bertolino Arthur Peter CENTRAL INDEX KEY: 0001426344 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36297 FILM NUMBER: 151239527 MAIL ADDRESS: STREET 1: 6475 CHRISTIE AVENUE SUITE 300 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-11-17 0 0001479290 Revance Therapeutics, Inc. RVNC 0001426344 Bertolino Arthur Peter C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BOULEVARD NEWARK CA 94560 0 1 0 0 EVP and Chief Medical Officer Common Stock 2015-11-17 4 S 0 5425 39.11 D 36329 D Common Stock 2015-11-17 4 S 0 36 39.55 D 36293 D Common Stock 2015-11-17 4 S 0 2277 39.11 D 34016 D Common Stock 2015-11-17 4 S 0 15 39.55 D 34001 D The Reporting Person sold an aggregate of 5,461 shares of restricted stock to settle a personal tax liability in connection with the November 15, 2015 vesting of certain shares of restricted stock that the Reporting Person acquired pursuant to a grant dated September 2, 2014. The Reporting Person sold an aggregate of 2,292 shares of restricted stock to settle a personal tax liability in connection with the November 15, 2015 vesting of certain shares of restricted stock that the Reporting Person acquired pursuant to a grant dated January 28, 2015. /s/ Gordon Ho, Attorney-in-fact 2015-11-17